Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Biocept, Inc.

< Previous 1 2 Next >
Biocept Announces a Delay in the Filing of its Quarterly Report on Form 10-Q
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports 2021 Fourth Quarter and Full Year Financial Results
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports Unaudited 2021 Revenue and Year-End Cash Balance
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Report 2021 Fourth Quarter and Full Year Financial Results on March 31, 2022
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Presentation at Molecular Medicine Tri-Con Meeting Highlights Potential of CNSide™ Assay to Support Development of Targeted Therapies for Metastatic Brain Cancer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Appoints Samuel D. Riccitelli as Interim President and Chief Executive Officer and Antonino Morales as Interim Chief Financial Officer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Names Darrell Taylor as Senior Vice President, General Counsel and Chief Compliance Officer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports an Increase in COVID-19 RT-PCR Testing Volume with Spread of the Omicron Variant
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Present at the H.C. Wainwright BioConnect Virtual Conference on January 10
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Launches Combined COVID-19 and Influenza Test to Provide Answers During Peak Flu Season
From Biocept, Inc.
Via Business Wire
Tickers BIOC
CORRECTING and REPLACING Biocept’s CNSide Cerebrospinal Fluid Assay Aids in Monitoring Treatment Response and Detects Actionable Biomarkers in Patients with Metastatic Breast Cancer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept’s CNSide Cerebrospinal Fluid Assay Aids in Monitoring Treatment Response and Detects Actionable Biomarkers in Patients with Metastatic Breast Cancer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports Third Quarter 2021 Financial Results
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Study Shows Biocept’s Switch-Blocker Technology Enhances Performance of Conventional PCR-Based Liquid Biopsy Assays in Detecting Rare Cancer Mutations
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Report Third Quarter 2021 Financial Results and Host Investor Conference Call on November 15, 2021
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Present at the LD Micro Main Event on October 13
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept’s CNSide Assay Identifies Tumor Cells and Actionable Treatment Biomarkers from Cerebrospinal Fluid in Patients with Metastatic Non-Small Cell Lung Cancer
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Reports Second Quarter 2021 Financial Results
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Report Second Quarter 2021 Financial Results and Host Investor Conference Call on August 16, 2021
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Medicare Issues Local Coverage Determination for Biocept’s Target Selector™ Breast Cancer Assay to Detect the HER2 Biomarker from Circulating Tumor Cells
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Welcomes Linda Rubinstein and Antonino Morales to Board of Directors, Names Director Samuel Riccitelli as Chairman
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Participate in Two July Investment Conferences
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Receives South Korean Patent for Primer-Switch Platform Used to Identify Rare Genetic Mutations, Including Cancer Biomarkers
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept Joins the Russell Microcap® Index
From Biocept, Inc.
Via Business Wire
Tickers BIOC
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
From Biocept, Inc.
Via Business Wire
Tickers BIOC DGX
Biocept Receives More Than 420,000 Samples During First Year of Offering COVID-19 Testing Service
From Biocept, Inc.
Via Business Wire
Tickers BIOC
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.